FDA Expects To Finish Several EU GMP Equivalency Determinations in 3 Years
This article was originally published in The Tan Sheet
Executive Summary
FDA expects to complete equivalency determinations for two or three countries during the three-year transition period established under the European Union-US. mutual recognition agreement on Good Manufacturing Practices, FDA Deputy Commissioner for External Affairs Sharon Smith Holston told a House Commerce/Oversight Subcommittee hearing Oct. 2.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning